A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects
Clinical trial NCT03742882 · COMPLETED
Trial details
- NCT number
- NCT03742882
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2019-06-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.